Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease

Stephen A. Harrison; Seth J. Baum; Nadege T. Gunn; Ziad H. Younes; Anita Kohli; Rashmee Patil; Margaret J. Koziel; Harinder Chera; Jeff Zhao; Manu V. Chakravarthy

doi:10.14309/ajg.0000000000001375

Back

Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease

Journal article

Open access

Peer reviewed

Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease

Stephen A. Harrison, Seth J. Baum, Nadege T. Gunn, Ziad H. Younes, Anita Kohli, Rashmee Patil, Margaret J. Koziel, Harinder Chera, Jeff Zhao and Manu V. Chakravarthy

The American journal of gastroenterology, Vol.116(12), pp.2399-2409

12/01/2021

DOI: https://doi.org/10.14309/ajg.0000000000001375

PMID: 34382947

Abstract

Liver

Files and links (1)

url

https://doi.org/10.14309/ajg.0000000000001375View

Published (Version of record) Open

Metrics

1 Record Views

See more details

Details

Title: Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease
Creators: Stephen A. Harrison - Pinnacle Clinical Research
Seth J. Baum - Excel Medical Clinical Trials, Boca Raton, Florida, USA
Nadege T. Gunn - Pinnacle Clinical Research
Ziad H. Younes - Gastro One
Anita Kohli - Arizona Liver Health
Rashmee Patil - Texas Research Institute
Margaret J. Koziel - Axcella Health
Harinder Chera - Axcella Health
Jeff Zhao - Axcella Health
Manu V. Chakravarthy - Axcella Health
Publication Details: The American journal of gastroenterology, Vol.116(12), pp.2399-2409
Publisher: Wolters Kluwer
Identifiers: 991005968853002656
Academic Unit: Internal Medicine
Language: English
Resource Type: Journal article